The National Cancer Institute (NCI)...

The National Cancer Institute (NCI) and the U fodder and Drug Administration (FDA) lately announced two new collaborative initiatives designed to facilitate the increase and use of better cancer treatments. individual of the initiatives will create a classification for submitting investigational new remedy applications to the FDA electronically that will streamline regulatory interactions and accelerate the overall regulatory review proces for recent cancer drugs. The FDA generally reviews investigational new drug applications in 30 days or les More information onward this system, the "Cancer Biomedical Informatics Grid (caBIG) project" is available online at http://cabig.nci.nih.gov. The other initiative creates cancer fellowship training programs aimed at developing a corps of physicians and scientists who are quicks in clinical research, the regulatory approval proces and translation of research breakthroughs to clinical practice. below this program, fellows will work in clinical oncology programs at NCI and in the technical and regulatory review programs at the FDA.

COPYRIGHT 2003 American Academy of Family Physicians

COPYRIGHT 2003 Gale Group